StockWatch
·

Eris Lifesciences Ltd Q3 FY26 Results

ERISQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue807.451.9%11.0%
Total Income807.471.5%10.4%
Expenditure645.003.6%4.8%
PBT145.2315.8%25.0%
Net Profit108.8319.1%25.2%
OPM32.74%3.63pp36.37pp
NPM13.48%3.43pp1.60pp
EPS7.3217.0%19.0%
View full financials

Informational and educational content only. Not investment advice.